Next, via immunoblotting, we quantified the expression of BIRC7/Livin and the effect of 0.5 mM aspirin on BIRC7/Livin in the protein proficient, p53 mutant SW480 CRC cell line. This evidence concerns the gene TP53 and colorectal carcinoma.